Bluepoint Secures 10 Billion Won Investment from ZVC and InBody

"Strengthening Global Partnerships"

Deep tech accelerator Bluepoint Partners announced on December 22 that it has secured an investment of 10 billion won to further advance its early-stage investment capabilities.

This investment round included Jet Venture Capital (ZVC) and global healthcare company InBody, with each contributing 5 billion won. The exact valuation of the investment round remains undisclosed. ZVC is a corporate venture capital (CVC) firm under LY Corporation, a joint venture holding company established by Naver and SoftBank.

The funds will be used to strengthen investments in startups with global competitiveness and to enhance technology commercialization processes. Bluepoint aims to maximize synergy with global companies ZVC and InBody by leveraging its expertise in deep tech and technology commercialization.

Bluepoint will actively utilize ZVC’s networks in Japan and the United States to establish global testbeds for its investment portfolio. At the same time, ZVC plans to discover and collaborate with domestic deep tech startups with global competitiveness through Bluepoint.

In partnership with InBody, Bluepoint will also accelerate innovation across various industries, including the bio and healthcare sectors. The strategy is to leverage InBody’s technology, infrastructure, and human resources through an acceleration approach, thereby facilitating rapid market exploration and growth.

Hwang Injun, CEO of ZVC, stated, "Bluepoint is the optimal partner, having established a unique position in the deep tech sector where technological expertise and early-stage verification capabilities are essential. With this investment, ZVC will actively enter the Korean deep tech ecosystem and combine our strengths to fully support the global growth of domestic technology companies."

Lee Yongkwan, CEO of Bluepoint, commented, "This investment is further recognition of Bluepoint’s investment expertise built over the past decade in the early-stage and deep tech sectors. Together with global companies ZVC and InBody, we will lead the global expansion of domestic deep tech startups."

Since its founding in 2014, Bluepoint has invested in over 400 companies, establishing itself as a leading accelerator in Korea. Notable investment outcomes include IPOs of Tomocube, Inventage Lab, S2W, and Nota. Bluepoint was also selected as the most preferred accelerator by entrepreneurs for two consecutive years in 2023 and last year by Startup Alliance.

Additionally, Bluepoint has continued to invest in powerful technology-driven fields such as nuclear fusion, quantum computing, and defense artificial intelligence (AI), areas that are rarely addressed by domestic investors. Based on this expertise, Bluepoint is currently collaborating with companies such as LG Electronics, LG Uplus, HD Hyundai Electric, and POSCO Holdings.